5-(6-methylpyridin-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

N-Isopropylhydroxylamine Hydrochloride>98.0%(N)(T)1g

2-(Chloromethyl)-4-nitropyridine, 100mg

(2,4-Dichloro-6-methylpyridin-3-yl)methanol, 97%, 250mg

1-(2-furyl)-3-(2-hydroxyphenyl)propane-1,3-dione, 95.0%, 1g

3,3'-((Oxybis(ethane-2,1-diyl))bis(oxy))bis(propan-1-amine), 95.0%, 1kg

3-Fluoro-5-((7-(methylsulfonyl)-1-oxo-2,3-dihydro-1H-inden-4-yl)oxy)benzonitrile, 98%, 100mg

Hexahidrato de sal disódica de 4-nitrofenilfosfato, 2,5 g

(S)-(-)-1,1'-Bi-2-naphthol>98.0%(HPLC)(T)5g

2-(tert-Butoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 250mg

(S)-1-(3-Nitrophenyl)ethanol, 97%, 5g

Palladium(II) Chloride>98.0%(T)5g

Bis[2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl]titanocene>98.0%(HPLC)25g